Ulcerative colitis
Conditions
Interventions
Experimental group:oral Kui-An-Ning-Fang
Control Group:oral mesalamine 3g/d
Sponsors
The First Affiliated Hospital of Kunming Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1) Age= 18 years old, = 65 years old; 2) The diagnosis meets the diagnostic criteria of the Chinese Guidelines for the Diagnosis and Treatment of Ulcerative Colitis (Xi'an, 2023); 3) Agree and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1) Patients with unclear diagnosis of colitis; 2) Patients with autoimmune diseases, infectious diseases and tumor diseases at the same time; 3) Patients with other serious heart, lung, kidney and other diseases; 4) Combined with retinal diseases, diabetes, malignant hypertension, lupus erythematosus and other connective tissue diseases; 5) 5) Patients who are participating in other drug clinical trials at the same time; 6) 6) The researcher believes that other reasons are not suitable for the trial participants.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mayo scoring; | — |
Secondary
| Measure | Time frame |
|---|---|
| C-reactive protein;Erythrocyte Sedimentation Rate;Albumin;Hemoglobin;Platelet; | — |
Countries
China
Contacts
Public ContactLuo Juan
The First Affiliated Hospital of Kunming Medical University
Outcome results
None listed